UK Surgeon Calls for Paradigm Shift in Surgical Education: PrecisionOS and CONMED Host Surgical Metaverse Conference with Guy’s and St Thomas’ NHS Trust at Renowned King’s College in London. 

VANCOUVER, BC, August 2, 2022. PrecisionOS, whose medical grade virtual reality (VR) solution is being utilized by institutions around the world, will co-host a VR surgical training conference with CONMED. Several junior surgeons, senior faculty members, and officials from Guy’s & St Thomas’ NHS Trust in England will participate on August 4, 2022, at the Gordon Museum of Pathology at King’s College London. 

Mr. Adil Ajuied, a Consultant Specialist Knee Surgeon, and a Lead with Academic Guy’s & St Thomas’ Hospital, was responsible for setting up the event. He states, “The challenges facing surgical training in the aftermath of the global pandemic are unprecedented. We are asking for the highest standards in clinical care and technical skill from our young surgeons while they struggle to support healthcare systems buckling under the strain of the aftermath of the pandemic. Surgical education and training require a paradigm shift in the way we interact, communicate, and educate core knowledge and technical skills. For these reasons, we have partnered with PrecisionOS and CONMED to deliver this virtual reality surgical training event. We are working closely with our VR partners to develop and establish innovative and robust modes of surgical training to upskill and empower the surgeons of the future.” 

Several of the many advantages that the PrecisionOS platform offers include frequent and relevant feedback providing an in-depth virtual operating room experience. Detailed performance metrics are provided during, and following, a procedure so that learners may assess their surgical skills in real-time and identify areas of improvement. This immediate feedback facilitates tangible performance improvements and increases surgical precision quickly.  

The focus of PrecisionOS is on clinically relevant and evidence-based training and education geared for all levels of surgeons and healthcare providers. “Our fundamental approach is to enhance, challenge and personalize surgical education and training towards proficiency. Given the impact well-trained healthcare providers can have on outcomes, the implications of our platform to deliver on that ability forms the core of our company” said Dr. Danny Goel, an orthopedic surgeon, and CEO of PrecisionOS.  

The August 4th event, brings together both delegates and presenters to meet live in virtual reality. This will be followed by breakout sessions where attendees will learn about the CONMED arthroscopic Hip and Infinity ACL reconstruction knee modules.  

About PrecisionOS  
PrecisionOS was founded in partnership with clinical orthopedic surgeon educators and an expert group of XR  developers to create simulation training for practicing surgeons, residents and surgical device representatives. Participants using PrecisionOS modules engage in a realistic operating environment, alone or in collaboration with other trainees anywhere in the world, test their knowledge and desire to try alternate approaches, receive instructive feedback and repeat procedures until achieving proficiency. With InVision, a patient specific planning tool, the company is expanding into the provision of next generation products for preoperative surgery, simulation training and education. PrecisionOS is based in Vancouver, BC, with collaborative affiliations with more than 50 major medical institutions in the U.S. and Canada. The company’s software is being used in more than 60 countries and 700 cities globally. 

About ConMed 
CONMED is a medical device manufacturer driven by a mission to empower healthcare providers to deliver exceptional patient outcomes worldwide. We provide the support our healthcare partners need to transform patient lives with superior products, deep clinical expertise, and education on cutting-edge advances in surgical technology and treatments.  

For more information, please visit 
Media Contact: Kate Castelo,